Medac Poised to Cement Japan Foothold in RA, Eyes Rare Disease Launch Too: CEO

Medac CEO Frank Lucaßen German drug maker Medac has begun making its full foray into the Japanese market. Armed with Japan’s only subcutaneous methotrexate (MTX) product, the company plans to first establish its presence in rheumatology, while having embarked on...read more